MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33/SLIT2/ROBO1 signalling pathway
2018 · Cancer Cell International · 70 citations
https://doi.org/10.1186/s12935-018-0563-6
B
Baishen Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
256
Citations
8
h-index
7
i10-index
Baishen Zhang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Lung Cancer Research Studies & Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers. The author has an h-index of 8, co-authored 24 publications.
ORCID: 0000-0002-9222-4882Papers by this author
worksDynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)
2022 · BMC Medicine · 30 citations
https://doi.org/10.1186/s12916-022-02595-8
Continuing immune checkpoint inhibitors after progression: Real-world patterns of care and outcomes in second-line treatment for extensive-stage small-cell lung cancer
2024 · Lung Cancer · 4 citations
https://doi.org/10.1016/j.lungcan.2024.108021
Superior Effectiveness of PD‐1 Inhibitor Plus Chemotherapy versus Bevacizumab Plus Chemotherapy as First‐Line Treatment for Non‐Small Cell Lung Cancer with Brain Metastases
2023 · Advanced Therapeutics · 1 citations
https://doi.org/10.1002/adtp.202300314
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat